SANDRA KOZLOWSKI: Open Payments
NPI 1558390955 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 57 payments from 11 companies in 2025. Trend: 2023 $454 · 2024 $714 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $360 |
| Madrigal Pharmaceuticals | 6 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $227 |
| Janssen Biotech, Inc. | 6 | $192 |
| Gilead Sciences, Inc. | 4 | $111 |
| PFIZER INC. | 5 | $103 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| Janssen Scientific Affairs, LLC | 1 | $81 |
| Aimmune Therapeutics, Inc. | 2 | $62 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, LINZESS, RINVOQ, XIFAXAN, EOHILIA, XELJANZ.
Industry payments across FL — which companies pay providers there.
